StockData

Microvast vs Novanta

MVST and NOVT side by side, both in electronic and other electrical equipment and components, except computer equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MVST and NOVT compare

Novanta is the larger company, worth 53 times as much as Microvast ($4.4B against $81.9M).

Novanta grew revenue faster over the last twelve months (7.6% versus −13.0% for Microvast).

Novanta scores higher on the StockData Score (12 against 7 for Microvast), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMVSTNOVT
Size and price
Market cap$81.9M$4.4B
Share price$0.213$115.33
Change, 1 year−94.5%11.1%
Change, 5 years−97.5%−28.0%
Beta (5Y)2.351.72
Employees1,9083,000
StockData Score
Total score712 (better)
Valuation score3 (better)2
Growth score12 (better)
Performance score03 (better)
Health score35 (better)
Dividend score00
Valuation
P/E–73.9×
P/S0.2× (better)4.2×
P/B0.2× (better)2.7×
EV/EBITDA–25.2×
P/FCF–38.2×
FCF yield−37.3%2.6% (better)
Fair value$1.57$111.19
Margin of safety86.5% (better)−3.7%
Growth
Revenue growth (TTM)−13.0%7.6% (better)
Revenue growth, 5Y average31.8% (better)10.7%
Net income growth (TTM)–0.66%
EPS growth (TTM)–−8.2%
EPS growth, 5Y average–3.3%
Profitability
Gross margin25.1%44.5% (better)
Operating margin−10.3%9.0% (better)
Net margin–6.0%
FCF margin−8.3%11.1% (better)
Return on equity–5.1%
Return on invested capital−7.0%6.3% (better)
Financial health
Debt / equity0.190.14 (better)
Net debt / EBITDA–−3.18
Interest coverage−7.5×–
Current ratio1.094.57 (better)
Altman Z-score−1.186.35 (better)
Piotroski F-score55
Dividends and buybacks
Buyback yield–1.2%
Shareholder yield0.00%1.2% (better)
Ownership
Held by institutions21.5%119%
Held by insiders46.8%0.73%
Insider net buying, 12 months−$169K (better)−$11.6M
Short interest, % of float9.8%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.